ScreenerHero

0QNOLonza Group Ltd

LSE · GB · Healthcare · Biotechnology · lonza.com
589.32CHF+0.74%Mkt Cap: —P/E: 14.98

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap—
Enterprise Value51.40B $
Revenue (TTM)7.84B $
Gross Profit2.91B $
Net Income (TTM)1.23B $
Revenue/Share112.22 USD
Last Price589.32 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees20.1K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)14.98
P/E (Forward)—
PEG—
EV/EBITDA18.84
EV/Revenue6.55
P/S—
P/B5.09
EPS (TTM)39.52
EPS (Forward)—
52W Range
560.2087% of range593.60
52W High593.60 CHF
52W Low560.20 CHF
Profitability
Gross Margin37.14%
Oper. Margin23.41%
EBITDA Margin34.78%
Profit Margin-1.60%
ROE12.90%
ROA5.44%
Growth
Revenue Growth11.20%
Earnings Growth39.20%
Cash Flow & Leverage
Operating CF1.64B $
CapEx (TTM)—
FCF Margin-22.81%
FCF Yield—
Net Debt4.20B $
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity51.12
Current Ratio1.66
Quick Ratio0.59
Book Value/Sh116.37 CHF
Cash/Share6.980 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate5.000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.74.43M
Float69.74M
Insiders0.09%
Institutions61.72%
Technical
SMA 50424.03 (+39.0%)
SMA 200436.80 (+34.9%)
Beta0.84
S&P 52W Chg19.18%
Avg Vol (30d)21.63K
Avg Vol (10d)76.48K
Technical Indicators
RSI (14)69.7
MACD16.6347
MACD Signal18.2716
MACD Hist.-1.6369
BB Upper604.61 CHF
BB Middle571.84 CHF
BB Lower539.06 CHF
BB Width11.46%
ATR (14)12.94 CHF
Vol Ratio (20d)1.10x